Image

Cardiac Amyloidosis in HFpEF Tunisian Patients

Exploring heart condition in Tunisian patients with heart failure symptoms.

Recruiting
60-90 years
All
Phase N/A
**Cardiac Amyloidosis in HFpEF Tunisian Patients** *Cardiac amyloidosis (CA)* is a condition where abnormal proteins called amyloids build up in the heart, causing heart problems. *HFpEF* stands for *Heart Failure with preserved Ejection Fraction*, which means the heart's pumping is normal but it struggles to fill with blood. This study focuses on older Tunisian patients with HFpEF to find out how common CA is among them. The study involves checking for CA in patients who have had HFpEF in the past year and have a heart wall thickness (*IVS thickness*) of 12mm or more. They will also use clinical tests and ultrasound to look for signs of CA. **Key Points**: - **Participation Requirements**: Must have had HFpEF in the last year and be over 60 years old. - **Exclusions**: Cannot participate if you have congenital heart disease or had a serious heart attack causing HFpEF. - **No Risks or Treatments**: This study primarily involves observation and diagnosis, not treatment. This research could help doctors diagnose CA earlier, improving outcomes for patients.
Study details
    Cardiac Amyloidosis
    Heart Failure With Preserved Ejection Fraction
    Echocardiography
    CMR
    Bone Scintigraphy
    Prevalence
    Diagnosis

NCT06201832

University Tunis El Manar

24 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.